Tech Company Financing Transactions
OrthoAccel Technologies Funding Round
HealthpointCapital Partners, Piper Jaffray Ventures and S3 Ventures participated in a $12 million Series C capital raise for OrthoAccel Technologies. The funding round was announced on 3/11/2016.
Transaction Overview
Company Name
Announced On
3/11/2016
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series C
Investors
Proceeds Purpose
Continuing to build on another year of dynamic sales growth and market penetration, this investment provides the resources needed to realize our next stage of market share growth. OrthoAccel's expansion plans include aggressive revenue growth internationally and in North America. The company is actively adding 18 new sales representatives, with nine dedicated to expanding direct sales in Europe. Headquartered in Houston, OrthoAccel's growth plans include adding 30 employees to support functions such as marketing, innovation, operations and clinical education.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6575 West Loop South 200
Bellaire, TX 77401
USA
Bellaire, TX 77401
USA
Phone
Website
Email Address
Overview
The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/11/2016: Bedly venture capital transaction
Next: 3/11/2016: Good Culture venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs